Skip to Main Content Go to Sitemap
SickKids

News & Stories

Read the latest news and stories in the SickKids newsroom. Looking to interview someone? Connect with our media team.

Go to article

December 5, 2019

Congratulations to the winners of the 2019 President’s Award

The President's Award recognizes staff, teams, students and/or volunteers who demonstrate superior leadership and collaboration resulting in major contributions to the organization.

Scientist looking into a microscope

December 5, 2019

High-quality stem cells enable researchers to better study almost any disease

Using whole genome sequencing, a collaborative team at SickKids and the University of Toronto has created high-calibre control induced pluripotent stem cells that can be used to study a variety of diseases.

Read news article

December 5, 2019

Genome testing for siblings of individuals with autism may detect diagnosis before symptoms appear

New research led by SickKids and the University of Alberta found testing the DNA of siblings of individuals with autism may be predictive of a future diagnosis even if symptoms aren’t yet apparent. Findings could lead to earlier therapeutic interventions.

December 4, 2019

Update on motherisk.org

SickKids has alerted the public and the medical community that the information currently on motherisk.org is not endorsed by, and in no way represents, SickKids or the former Motherisk Helplines.

SickKids hospital exterior

December 3, 2019

Unlocking the door to potential therapeutic treatments for serious complications from infections

SickKids scientists used the Canadian Light Source (CLS) at the University of Saskatchewan to solve the structure of an enzyme that could help burn victims and prevent deaths from different kinds of infections.

Go to article

November 27, 2019

Intellectual sparing in children with rare brain cancer: New research demonstrates better cognitive outcomes with less invasive treatment for paediatric medulloblastoma

New research findings offer new evidence that proton radiotherapy – a type of radiation therapy – could effectively treat medulloblastoma in children without causing the level of impairment to the brain that is usually caused by standard treatments.

Read about drug therapy for inflammatory bowel disease

November 26, 2019

New research shows potential drug therapy reduces effects of rare intestinal disease

A drug typically used to treat rheumatic conditions could have therapeutic benefit for patients with a rare inflammatory bowel disease gene mutation. Study results have lead to a novel clinical trial led by SickKids.

Go to article

November 22, 2019

SickKids celebrates World Children’s Day

SickKids commemorated World Children’s Day and the 30th anniversary of the UN Convention on the Rights of the Child (UNCRC) with a day full of art, literacy and education.

Go to article

November 22, 2019

A great place to work! SickKids makes Canada’s Top 100 Employers for fifth straight year

SickKids is a great place to work and a great place to be a patient - sometimes both. Just ask staff members like Katie, Leo and Amy.

SickKids hospital exterior

November 19, 2019

Statement: Motherisk website not operated by SickKids

SickKids wishes to alert the public and the medical community that the motherisk.org website is currently being operated by a third party and in no way represents SickKids or the former Motherisk Helplines.

Go to article

November 14, 2019

SickKids is No. 1 for researcher intensity on Canada’s Top 40 Research Hospitals 2019 list

SickKids is proud to be one of Canada’s Top 40 Research Hospitals. In 2019, SickKids Research Institute holds the number one spot for researcher intensity.

Go to article

November 12, 2019

New study finds higher risk of mental health outcomes that persist over time in mothers and siblings of children with cancer

Mothers and siblings of children with cancer experience higher rate of mental health-related outpatient visits decades after the original cancer diagnosis, according to new research co-led by SickKids and ICES.

Back to Top